Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING
JIB
GLOBETECH PUBLISHING

New Metabolomics Kit Enables Use with Specialized Mass Spectrometer

By BiotechDaily International staff writers
Posted on 26 Mar 2013
Image: The new “AbsoluteIDQ p150” metabolomics kit (Photo courtesy of Biocrates).
Image: The new “AbsoluteIDQ p150” metabolomics kit (Photo courtesy of Biocrates).
A state-of-the-art metabolomics-based research kit has been specially designed for use with a triple stage quadrupole mass spectrometer, enabling additional laboratories to use such kits.

Biocrates Life Sciences AG (Innsbruck, Austria) introduced “AbsoluteIDQ p150,” the new edition of its well-established line of metabolomics-based research kits. The kit has been available for use with AB Sciex and Waters mass spectrometry systems, and has now been designed to also run on Thermo Scientific’s “TSQ Vantage” Triple Stage Quadrupole Mass Spectrometer, enabling more research labs to harness the power of targeted metabolite quantification with a ready-to-use kit system. Combined with a robust new ion source, second-generation ion optics, and hyperbolic quadrupoles, the “TSQ Vantage” mass spectrometer delivers both higher sensitivity and lower chemical noise.

AbsoluteIDQ p150 provides extensive metabolic information from a single targeted assay, quantifying 158 metabolites using a FIA-MS/MS method. It features the proprietary “MetIDQ” software, requires minute sample volumes (10 µL), and is suitable for use with a wide range of biological samples, making it an excellent choice with a cost-effective solution to measure endogenous metabolites under quality-controlled conditions in a researcher’s own laboratory. The Biocrates AbsoluteIDQ kits have been successfully applied in many different areas, including oncology, endocrinology, diabetes, nephrology, sepsis, and CNS disorders, in both clinical and pharmaceutical research. Biocrates mass spectrometry-based, standardized metabolomic kits provide multiplexing potential and superior accuracy and precision.

Related Links:
Biocrates




comments powered by Disqus

Channels

Genomics/Proteomics

view channel
Image: Diagram illustrates the innovative process that could lead to more effective drugs against influenza infection (Photo courtesy of the Hebrew University of Jerusalem).

Researchers Show How the Influenza Virus Blocks Natural Killer Cell Recognition

A team of molecular virologists has described how the influenza virus evolved a defense mechanism to protect it from attack by the immune system's natural killer (NK) cells. The recognition of pathogen-infected... Read more

Drug Discovery

view channel
Image: Synthetic ion transporters can induce apoptosis by facilitating chloride anion transport into cells (Photo courtesy of the University of Texas, Austin).

Experimental Drug Kills Cancer Cells by Interfering with Their Ion Transport Mechanism

An experimental anticancer drug induces cells to enter a molecular pathway leading to apoptosis by skewing their ion transport systems to greatly favor the influx of chloride anions. To promote development... Read more

Therapeutics

view channel
Image: Liver cells regenerated in mice treated with a new drug (right) compared with a control group (center) after partial liver removal. Healthy liver cells are shown at left (Photo courtesy of Marshall et al, 2014, the Journal of Experimental Medicine).

New Drug Triggers Liver Regeneration After Surgery

Investigators have revealed that an innovative complement inhibitor decreases complement-mediated liver cell death, and actually stimulates postsurgery liver regrowth in mice. Liver cancer often results... Read more

Business

view channel

Partnership Established to Decode Bowel Disease

23andMe (Mountain View, CA,USA), a personal genetics company, is collaborating with Pfizer, Inc. (New York, NY, USA), in which the companies will seek to enroll 10,000 people with inflammatory bowel disease (IBD) in a research project designed to explore the genetic factors associated with the onset, progression, severity,... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.